Company: VEEAW
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001213900-25-002701
Chunk: 48

Company: VEEA INC.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 48
---
 in the relevant jurisdiction. In such an event, potential competitors might be
able to enter the market with similar or identical products or technology, which could have a material adverse effect on Veea’s
business, financial condition, results of operations, and prospects.

Changes in patent law in the U.S. or worldwide could diminish the value of patents in general, thereby impairing Veea’s ability to protect any products Veea may develop and Veea’s technology.

Changes in either the patent
laws or interpretation of patent laws in the U.S. and worldwide, including patent reform legislation such as the Leahy-Smith America
Invents Act (the “Leahy-Smith Act”), could increase the uncertainties and costs surrounding the prosecution
of any owned or in-licensed patent applications and the maintenance, enforcement or defense of any in-licensed issued patents and issued
patents Veea may own or in-license in the future. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These
changes include provisions that affect the way patent applications are prosecuted, redefine prior art, provide more efficient and cost-effective
avenues for competitors to challenge the validity of patents, and enable third-party submission of prior art to the USPTO during patent
prosecution and additional procedures to attack the validity of a patent at USPTO administered post-grant proceedings, including post-grant
review, inter partesreview, and derivation proceedings. Assuming that other requirements for patentability are met, prior to
March 2013, in the U.S., the first to invent the claimed invention was entitled to the patent, while outside the U.S., the first to file
a patent application was entitled to the patent. After March 2013, under the Leahy-Smith Act, the U.S. transitioned to a first-to-file
system in which, assuming that the other statutory requirements for patentability are met, the first inventor to file a patent application
will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. As
such, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of Veea’s
patent applications and the enforcement or defense of patents to issue, all of which could have a material adverse effect on Veea’s
business, financial condition, results of operations and prospects.

In addition, the patent positions of companies
in the development and commercialization of biologics and pharmaceuticals are particularly